Strategic Alliances, Partnerships & Collaborations Analysis – June 2018

After last month’s flurry of transactions, business calmed down as it often does during the start of summer. Here are the key deals and trends from mid-June through the third week of July.

Strategic collaboration was noticeably slow, in terms of both volume and impact with collaborations between diagnostics firms and academic institutions and nonprofits furnishing most of the impetus. Of course, there were a few deals pairing heavy hitters from the private sector, including the collaboration of

  • Illumina and PerkinElmer to codevelop metagenomic sequencing workflow enabling DNA extraction and sequencing from samples without the need to culture the bacteria
  • Illumina and OrigiMed to develop new molecular oncology assays; and
  • Bio-Rad and Bruker to comarket workflow solutions for pathogen detection and confirmation.

The other salient trend during the period was the trio of strategic alliances targeting the China market with Predicine, Agena Bioscience and Berlin, Germany-based CeGaT teaming with local partners to provide diagnostics services to the vast Chinese market.

The headliner on the consumer genetics front was Nutrisystem’s partnering with Akesogen and Genetic Direction to launch DNA Body Blueprint, a genetic analysis test in which DNA from cheek swabs is used to generate personalized information on an individual customer’s nutrition, metabolism and eating behaviors for use in tailoring individualized weight loss plans.

Close

EMAIL ADDRESS


PASSWORD
EMAIL ADDRESS

FIRST NAME

LAST NAME

TITLE

COMPANY

CITY / STATE

Try Premium Membership

(-0000g2)